1-4 of 4
Hidemi Takahashi
Close
Sort by
Journal Articles

Upregulation of PD-L1 on Myeloma Cells By Immunomodulatory Agents Potentiates the Effect of Durvalumab

Mariko Ishibashi, PhD, Junichi Yamamoto, PhD, Takumi Ito, PhD, Hiroshi Handa, MD PhD, Koiti Inokuchi, MD PhD, Hidemi Takahashi, MD PhD, Hideto Tamura, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4439.
https://doi.org/10.1182/blood-2018-99-112322
Published: 2018
Journal Articles

Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes

Asaka Kondo, Taishi Yamashita, Hideto Tamura, Wanhong Zhao, Takashi Tsuji, Masumi Shimizu, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata
Journal: Blood
Blood (2010) 116 (7): 1124–1131.
https://doi.org/10.1182/blood-2009-12-255125
Published: 2010
Includes: Supplemental data
Journal Articles

Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.

Asaka Kondo, Hideto Tamura, Taishi Yamashita, Chikako Sato, Zhao Wanhong, Takashi Tsuji, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata
Journal: Blood
Blood (2009) 114 (22): 2766.
https://doi.org/10.1182/blood.V114.22.2766.2766
Published: 2009
Journal Articles

Expression and Function of B7.2 and B7-H2 Molecules on Myeloma Cells

Taishi Yamashita, Hideto Tamura, MD, PhD, Chikako Sato, Asaka Kondo, Eiji Shinya, Hidemi Takahashi, Lieping Chen, Takashi Tsuji, Kazuo Dan, Kiyoyuki Ogata, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2722.
https://doi.org/10.1182/blood.V112.11.2722.2722
Published: 2008